https://scholars.lib.ntu.edu.tw/handle/123456789/580325
標題: | Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment | 作者: | YU-YUN SHAO ZHONG-ZHE LIN PO-CHIN LIANG YU-WEN TIEN ANN-LII CHENG |
公開日期: | 2009 | 卷: | 29 | 期: | 5 | 起(迄)頁: | 1665-1667 | 來源出版物: | Anticancer Research | 摘要: | Bowel perforation is a rare but life-threatening complication of bevacizumab, a new anticancer treatment. Patients with bowel perforation usually present with acute abdominal symptoms. Here a case history is presented to highlight a pancreatic cancer patient on bevacizumab chemotherapy who developed empyema as the first manifestation of gastric perforation. This unusual presentation warns physicians that bevacizumab-related bowel perforation can arise as a thoracic complication, without typical gastrointestinal manifestations, in an advanced cancer patient. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650083184&partnerID=40&md5=50f7a6348add00d04c5342cb205cef22 https://scholars.lib.ntu.edu.tw/handle/123456789/580325 |
SDG/關鍵字: | antineoplastic agent; bevacizumab; cefepime; cetuximab; adult; advanced cancer; article; cancer patient; cancer therapy; case report; clinical feature; computer assisted tomography; dyspnea; empyema; fever; human; male; pancreas abscess; pancreas cancer; priority journal; stomach perforation; thorax radiography; Antibodies, Monoclonal; Antineoplastic Agents; Empyema; Humans; Male; Middle Aged; Pancreatic Neoplasms; Tomography, X-Ray Computed |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。